NEW YORK (Reuters Health) – Physicians caring for women who are at increased risk for breast cancer should discuss with them the risks and benefits of specific chemoprevention…
Zachary Bloomgarden, MD, Clinical Professor at Mount Sinai Hospital, presents the case of a 48-year-old woman with diabetes who is currently taking metformin and glimepiride but is experiencing weight gain. He discusses…
NEW YORK (Reuters Health) – Contrary to a historically pessimistic outlook, high-risk prostate cancer can be controlled with moderate high-dose radiation treatment and prolonged androgen-deprivation therapy (ADT). That…
By Will Boggs, MD NEW YORK (Reuters Health) – Carboplatin plus pemetrexed improves survival over pemetrexed alone in ambulatory patients with advanced non-small-cell lung cancer (NSCLC), randomized trial…
NEW YORK (Reuters Health) – An updated meta-analysis supports the strategy of giving intravesical chemotherapy (IVC) immediately after bladder tumor resection to reduce the risk of recurrence. “However,…
NEW YORK (Reuters Health) – The cumulative incidence of osteonecrosis of the jaw was about 2% over 6 years among women with early breast cancer who received intensive…
By David Douglas NEW YORK (Reuters Health) – Dual HER2 blockade didn’t increase heart problems in a meta-analysis of data from patients with HER2-positive breast cancer. “The combination…
NEW YORK (Reuters Health) – For patients with head and neck or esophageal cancer undergoing chemoradiotherapy, enteral nutrition enriched with n-3 fatty acids helps preserve body mass. The…
NEW YORK (Reuters Health) – Fidaxomicin, approved by the US Food and Drug Administration in 2011 for the treatment of Clostridium difficile-associated diarrhea, is particularly effective in cancer…
By Robert Saunders NEW YORK (Reuters Health) – When papillary thyroid cancer spreads to lymph nodes in the neck, percutaneous laser ablation may spare patients further invasive surgery.…
